TY  - JOUR

T1  - Long-term safety of abrocitinib in moderate-to-severe atopic dermatitis: integrated analysis by age

JO  - The Journal of Allergy and Clinical Immunology: In Practice

UR  - https://eprints.whiterose.ac.uk/id/eprint/224683

PY  - 2025/03/11

AU  - Cork MJ

AU  - Deleuran M

AU  - Geng B

AU  - Silverberg JI

AU  - Simpson EL

AU  - Stein Gold LF

AU  - Irvine AD

AU  - Romero W

AU  - Valdez H

AU  - Fan H

AU  - Alderfer J

ED  - 

DO  - DOI: 10.1016/j.jaip.2025.02.040

PB  - Elsevier BV

VL  - 13

IS  - 5

SP  - 1164

EP  - 1175.e2

Y2  - 2025/11/23

ER  -